Cerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial Officer

AURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological disease, has appointed Guy Anthony as Chief Financial Officer.

Read Full Article

Previous
Previous

Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing

Next
Next

Hope grows for epilepsy patients as clinical trial enters next phase